Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
May 28  •  01:52PM ET
137.16
Dollar change
+21.32
Percentage change
18.41
%
Today, 10:06 AMAgilent beats fiscal Q2 2026 estimates, raises FY26 outlook as Bank of America upgrades to Buy with $145 target
Index
S&P 500
P/E
27.55
EPS (ttm)
4.98
Insider Own
0.33%
Shs Outstand
282.22M
Perf Week
20.55%
Market Cap
38.76B
Forward P/E
20.84
EPS next Y
6.58
Insider Trans
-0.60%
Shs Float
281.66M
Perf Month
19.41%
Enterprise Value
40.31B
PEG
2.27
EPS next Q
1.49
Inst Own
92.72%
Perf Quarter
13.39%
Income
1.41B
P/S
5.36
EPS this Y
7.90%
Inst Trans
0.91%
Perf Half Y
-10.70%
Sales
7.23B
P/B
5.44
EPS next Y
9.13%
ROA
11.21%
Perf YTD
0.80%
Book/sh
25.24
P/C
21.45
EPS next 5Y
9.19%
ROE
21.33%
52W High
160.27 -14.42%
Perf Year
23.71%
Cash/sh
6.39
P/FCF
35.66
EPS past 3/5Y
3.03% 14.68%
ROIC
13.90%
52W Low
108.35 26.59%
Perf 3Y
13.91%
EV/EBITDA
21.45
Sales past 3/5Y
0.48% 5.41%
Gross Margin
55.95%
Volatility
3.18% 3.01%
Perf 5Y
-0.70%
EV/Sales
5.57
EPS Y/Y TTM
4.17%
Oper. Margin
22.15%
ATR (14)
4.71
Perf 10Y
199.36%
Quick Ratio
1.62
Sales Y/Y TTM
9.11%
Profit Margin
19.55%
RSI (14)
77.44
Current Ratio
2.10
EPS Q/Q
58.79%
SMA20
18.86%
Beta
1.21
Debt/Eq
0.47
Sales Q/Q
10.01%
SMA50
18.85%
Rel Volume
2.44
Prev Close
115.84
Employees
18100
LT Debt/Eq
0.43
SMA200
5.89%
Avg Volume
2.15M
Price
137.16
IPO
Nov 18, 1999
Option/Short
Yes / Yes
Trades
Volume
3,613,322
Change
18.41%
Date Action Analyst Rating Change Price Target Change
TodayUpgrade BofA Securities Neutral → Buy $145
May-27-26Initiated RBC Capital Mkts Outperform $153
Jan-20-26Initiated HSBC Securities Buy $180
Jan-05-26Upgrade Evercore ISI In-line → Outperform $160
Dec-15-25Upgrade Barclays Equal Weight → Overweight $165
Dec-09-25Initiated Goldman Buy $170
Dec-02-25Initiated Morgan Stanley Overweight $270
Oct-08-25Upgrade UBS Neutral → Buy $170
Oct-08-25Initiated Rothschild & Co Redburn Buy $165
Feb-10-25Upgrade Barclays Underweight → Equal Weight $135 → $145
Today 01:50PM
12:12PM
09:57AM
09:47AM
08:00AM
01:01AM Loading…
01:01AM
May-27-26 04:16PM
04:05PM
May-26-26 09:17AM
08:00AM
08:00AM
May-22-26 08:00AM
May-21-26 08:00AM
May-20-26 04:27PM
May-19-26 08:00AM
04:15PM Loading…
May-11-26 04:15PM
May-08-26 04:30PM
May-04-26 05:53PM
08:00AM
Apr-28-26 04:15PM
Apr-15-26 08:00AM
Apr-01-26 08:00AM
Mar-26-26 08:00AM
Mar-19-26 08:00AM
Mar-11-26 08:00AM
07:28AM
05:55AM
Mar-10-26 11:11AM
10:01AM
Mar-09-26 02:30PM
12:29PM Loading…
12:29PM
07:00AM
06:12AM
03:00AM
Mar-06-26 12:29PM
Mar-02-26 09:15AM
Feb-28-26 10:23PM
Feb-27-26 07:09AM
Feb-26-26 12:54PM
06:54AM
12:06AM
Feb-25-26 09:01PM
08:00PM
07:25PM
04:24PM
04:17PM
04:05PM
01:46AM
Feb-24-26 09:55PM
02:35PM
07:17AM
Feb-23-26 10:21PM
04:15PM
Feb-20-26 09:15AM
02:06AM
Feb-12-26 05:35PM
Feb-11-26 04:15PM
08:00AM
06:45AM
Feb-09-26 11:19AM
Feb-04-26 08:00AM
Feb-02-26 04:15PM
Jan-29-26 05:20PM
Jan-23-26 04:20PM
11:40AM
08:00AM
Jan-21-26 07:03AM
Jan-20-26 08:20PM
07:55AM
Jan-13-26 01:52PM
Jan-07-26 11:03AM
Jan-06-26 03:06PM
Dec-24-25 11:30AM
Dec-16-25 08:31AM
Dec-12-25 09:14AM
Dec-11-25 09:19AM
Dec-09-25 10:31PM
09:15AM
08:16AM
Dec-05-25 06:09AM
Dec-04-25 06:50AM
12:05AM
Dec-01-25 09:15AM
08:00AM
Nov-29-25 12:53PM
Nov-28-25 09:02AM
Nov-26-25 02:18PM
05:14AM
Nov-25-25 12:42PM
12:00AM
Nov-24-25 06:30PM
06:01PM
06:00PM
05:22PM
05:20PM
04:31PM
04:10PM
03:20AM
Nov-23-25 07:37AM
Nov-22-25 10:01PM
Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Diagnostics Markets, Applied Markets, and Agilent CrossLab. The Life Sciences and Diagnostics Markets segment offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. The Applied Markets segment refers to the application-focused solutions that include instruments and software that enable customers to identify, quantify, and analyze the physical and biological properties of substances and products. The Agilent CrossLab segment spans the entire lab with its extensive services and consumables portfolio in addition to software and laboratory automation solutions. The company was founded in May 1999 and is headquartered in Santa Clara, CA.
CEOMr. Padraig McDonnell
VPMr. Rodney Gonsalves
Senior VP & President of Agilent CrossLab GroupMs. Angelica A. Riemann
Senior VP and President of Life Sciences & Diagnostics Markets GroupDr. Simon May
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dolsten MikaelDirectorDec 01 '25Sale149.812,600389,5114,973Dec 03 04:04 PM
Gonsalves RodneyV.P., Corporate ControllerNov 26 '25Sale154.993,000464,95631,846Dec 01 04:29 PM
Dolsten MikaelDirectorDec 01 '25Proposed Sale149.812,600389,510Dec 01 04:26 PM
Gonsalves RodneyOfficerNov 26 '25Proposed Sale154.993,000464,956Nov 26 02:26 PM
MCDONNELL PADRAIGPresident and CEONov 18 '25Sale143.24911130,49232,058Nov 20 05:22 PM
MCDONNELL PADRAIGOfficerNov 18 '25Proposed Sale143.24911130,492Nov 18 10:37 AM
MCDONNELL PADRAIGPresident and CEONov 12 '25Option Exercise109.8612,4901,372,15145,938Nov 14 04:02 PM
MCDONNELL PADRAIGPresident and CEONov 12 '25Sale150.0012,4901,873,50033,448Nov 14 04:02 PM
MCDONNELL PADRAIGOfficerNov 12 '25Proposed Sale150.0012,4901,873,500Nov 12 10:03 AM
McMahon Robert W.Former OfficerSep 09 '25Proposed Sale126.215,781729,591Sep 09 04:26 PM
McMahon Robert W.Former OfficerSep 04 '25Proposed Sale128.6215,3031,968,224Sep 04 04:39 PM
MCDONNELL PADRAIGPresident and CEOSep 02 '25Sale124.882,000249,76033,448Sep 04 03:36 PM
MCDONNELL PADRAIGOfficerSep 02 '25Proposed Sale124.882,000249,760Sep 02 03:30 PM
McMahon Robert W.Former OfficerAug 29 '25Proposed Sale124.9628,0813,508,993Aug 29 03:46 PM
Ancher-Jensen HenrikFormer OfficerAug 29 '25Proposed Sale125.0421,6442,706,366Aug 29 09:59 AM
MCDONNELL PADRAIGPresident and CEOAug 01 '25Sale113.452,000226,90035,448Aug 04 04:15 PM
MCDONNELL PADRAIGOfficerAug 01 '25Proposed Sale113.452,000226,900Aug 01 10:32 AM
MCDONNELL PADRAIGPresident and CEOJul 01 '25Sale117.441,508177,10037,448Jul 03 04:46 PM
MCDONNELL PADRAIGOfficerJul 01 '25Proposed Sale117.441,508177,100Jul 01 12:45 PM
Brown Judy LDirectorJun 18 '25Sale116.5389041,677Jun 23 12:12 PM